J.&J. Booster Protects Against Severe Omicron, Study Says December 30, 2021 Auto Bot Clinical Trials, Coronavirus Omicron Variant, Johnson & Johnson, Research, South Africa, Vaccination and Immunization 0 Two shots of the vaccine reduced the risk of hospitalization from the fast-spreading variant by 85 percent, a clinical trial found.